Generic drug maker Juno can’t withdraw admission ahead of trial over Velcade patent
Intellectual Property 2019-04-24 1:32 pm | Melbourne
A judge has refused an application by generic drug maker Juno Pharmacueticals to withdraw an admission in a battle with Millennium Pharmaceuticals over its cheap version of breakthrough cancer drug Velcade, denying Juno a potential defence to allegations of patent infringement.
For information on rights and reprints, contact subscriptions@lawyerly.com.au